We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| AmerisourceBergen Corp | NYSE:ABC | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 179.98 | 0 | 01:00:00 |
From May 2021 to May 2024
By Robb M. Stewart
AmerisourceBergen Corp. on Wednesday raised its annual earnings forecast following the completion of its purchase of the majority of Walgreens Boots Alliance Inc.'s Alliance Healthcare businesses for $6.275 billion in cash and two million shares.
The drug distributor said it now expects adjusted earnings of between $8.90 and $9.10 a share for fiscal 2021, where it previously anticipated $8.45 to $8.60.
Revenue for the year is expected to be at least $210 billion, compared with earlier guidance for growth in the high-single-digits percent range, AmerisourceBergen said. The company logged revenue of $189.9 billion in fiscal 2020.
AmerisourceBergen said it continues to have a strong performance across its businesses.
With the completion of the sale of its Alliance Healthcare businesses, Walgreens Boots said it would use the proceeds to reduce debt and accelerate growth of its core retail pharmacy and healthcare businesses.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
June 02, 2021 07:51 ET (11:51 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year AmerisourceBergen Chart |
1 Month AmerisourceBergen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
